Sabin Vaccine Institute recibe subsidio de $10 millones para elevar la confianza en las vacunas
13 mars 2020 09h45 HE
|
The Sabin Vaccine Institute
WASHINGTON, March 13, 2020 (GLOBE NEWSWIRE) -- El Sabin Vaccine Institute (Sabin), anunció hoy que recibió un subsidio de tres años por un valor de $10,4 millones para solidificar la aceptación de...
Sabin Vaccine Institute recebe US $ 10 milhões para elevar a confiança nas vacinas
13 mars 2020 09h45 HE
|
The Sabin Vaccine Institute
WASHINGTON, March 13, 2020 (GLOBE NEWSWIRE) -- O Sabin Vaccine Institute (Sabin) anunciou hoje que recebeu uma doação de três anos no valor de US $ 10,4 milhões para solidificar a aceitação da...
サビン･ワクチン･インスティテュート、ワクチンの信頼性向上のために1,000万ドル (約10億5,800万円) の助成金を獲得
13 mars 2020 09h45 HE
|
The Sabin Vaccine Institute
ワシントン発, March 13, 2020 (GLOBE NEWSWIRE) -- サビン･ワクチン･インスティテュート (Sabin Vaccine Institute、略称「サビン」) は本日、同組織がワクチン受容を促進するため、3年間で1,040万ドル (約10億5,800万円) の助成金を受け取ったことを発表した。2019年、世界保健機関 (WHO)...
Sabin疫苗研究所获1000万美元拨款以提升对疫苗的信心
13 mars 2020 09h45 HE
|
The Sabin Vaccine Institute
华盛顿, March 13, 2020 (GLOBE NEWSWIRE) -- Sabin疫苗研究所（以下称“Sabin”）今日宣布，该所已获得一项为期三年、价值1040万美元的拨款， 用于增强疫苗接受水平。2019年，世界卫生组织将疫苗犹豫（在有可用疫苗的情况下不愿或拒绝接种疫苗）确定为全球健康面临的十大威胁之一。 ...
Sabin Vaccine Institute Receives $10M Grant to Raise Confidence in Vaccines
12 mars 2020 10h00 HE
|
The Sabin Vaccine Institute
WASHINGTON, March 12, 2020 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced it has received a three-year grant valued at $10.4 million to strengthen vaccine acceptance. In...
SABIN VACCINE INSTITUTE STRENGTHENS EBOLA SUDAN AND MARBURG VACCINES PROGRAM WITH ADDITIONAL NIAID PARTNERSHIP
05 mars 2020 10h00 HE
|
The Sabin Vaccine Institute
Washington, DC, March 05, 2020 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that it has partnered with the Vaccine Research Center (VRC), National Institute of Allergy and...
Sabin Vaccine Institute Appoints Filip Dubovsky to Board of Trustees
17 oct. 2019 10h00 HE
|
The Sabin Vaccine Institute
Washington, D.C., Oct. 17, 2019 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that Dr. Filip Dubovsky, head of clinical engagement and policy at AstraZeneca, has joined its...
Sabin Vaccine Institute Receives $20.5 Million From BARDA With Potential of up to $128 Million to Develop Ebola Sudan and Marburg Vaccines
01 oct. 2019 09h00 HE
|
The Sabin Vaccine Institute
WASHINGTON, Oct. 01, 2019 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced a funding award of $20.5 million with options for an additional $107.5 million from the Biomedical...
Sabin Vaccine Institute Elects New Trustees Bringing Expertise to Support Program Growth
13 août 2019 08h00 HE
|
The Sabin Vaccine Institute
Washington, D.C., Aug. 13, 2019 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) announces the appointment of three new members to its Board of Trustees. Joining the Board are Drs....
GSK Grants Exclusive Technology License for Clinical-Stage Ebola Vaccines to Sabin Vaccine Institute
06 août 2019 07h00 HE
|
The Sabine Vaccine Institute ; GSK
Transfer from GSK and partnership with NIAID will enable Sabin to advance development of the candidate vaccines LONDON and WASHINGTON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- GSK and the Sabin Vaccine...